PPARγ seems to produce improvement in the epithelial-to-mesenchymal transition and tubulointerstitial fibrosis by up-regulating FAK activation to ameliorate diabetic nephropathy (Yan et al., 2019). The gene discussed is PTK2; the disease is diabetic kidney disease.